Development of a lung immune prognostic index-based nomogram model for predicting overall survival and immune-related adverse events in non-small cell lung cancer patients treated with sintilimab
LIPI-based nomograms effectively predicted OS and irAEs in sintilimab-treated NSCLC patients, offering valuable tools for personalized treatment and clinical decision-making.
Authors
- Ran Sang (ORCID: https://orcid.org/0000-0002-1256-2372)
- Lingti Kong (ORCID: https://orcid.org/0000-0003-0769-9363)
- Kaikai Fan
- Jianming Xu (ORCID: https://orcid.org/0000-0003-4467-6021)
- Tingting Peng
- Yue Dou
Institutions
- Bengbu Medical College (CN)
- Suzhou Municipal Hospital (CN)
- First Affiliated Hospital of Bengbu Medical College (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3389/fimmu.2025.1569689
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.14